Henry M. Kuerer, Aman U. Buzdar, Elizabeth A. Mittendorf, Francisco J. Esteva, Anthony Lucci, Luis M. Vence, Laszlo Radvanyi, Funda Meric-Bernstam, Kelly K. Hunt and William Fraser Symmans Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast Cancer 117
Version of Record online: 24 AUG 2010 | DOI: 10.1002/cncr.25399
Single-dose preoperative monotherapy with trastuzumab for patients with HER2-positive DCIS results in the early ability to mount antibody dependent cellular cytotoxicity mediated through natural killer cells and may also induce T-cell dependent humoral immunity.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field